STJ  St. Jude Medical Inc.




Health Care


Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.


Vuru Grade


Current Price

-0.12 (-0.18%)

Growth Price

Overvalued by 18.69%

Stability Price

Overvalued by 69.12%

Company Metrics

  • 19.31 P/E
  • 3.34 P/S
  • 4.56 P/B
  • 3.46 EPS
  • 14.54% Cash ROIC
  • 0.54 Cash Ratio
  • 1.08 / 1.62% Dividend
  • 2.07M Avg. Vol.
  • 18.756B Market Cap.

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


St. Jude Medical to pay $14.25 million in Riata lawsuits
Minneapolis Star Tribune - Feb 27, 2015
St. Jude Medical Inc. has agreed to pay up to $14.25 million to settle about 950 claims from patients that their Riata defibrillator leads were prematurely degrading.
St. Jude Medical to settle suits over product linked to deaths - Minnesota Public Radio News
Settlement Reached in Lawsuits And Claims Involving Riata Defibrillator Leads - Virtual-Strategy Magazine (press release)
St. Jude Medical to Present at the Barclays Global Healthcare Conference
Business Wire (press release) - Feb 27, 2015
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) will present at the Barclays Healthcare Conference on Wednesday, March 11 in Miami.
St. Jude Medical Receives $73.68 Average PT from Brokerages (NYSE:STJ)
The Legacy - Feb 28, 2015
Shares of St. Jude Medical (NYSE:STJ) have earned a consensus rating of “Buy” from the twenty-one ratings firms that are presently covering the stock, American Banking and Market News reports.
Market Update: St. Jude Medical Inc (NYSE:STJ) - St. Jude Medical to Present ... - Jutia Group
Post-Earnings Research - St. Jude Medical
MarketWatch - Feb 24, 2015 has issued free post-earnings research on St. Jude Medical Inc. STJ, -2.39% On January 28, 2015, the company reported its financial results for Q4 FY14 and full year FY14 (period ended January 03, 2015).
Notable Downgrades: Rosetta Resources (ROSE), American Airlines (AAL), St ...
Wall Street Pit - Feb 24, 2015
As for passive income investors, the company pays shareholders $1.08 per share annually in dividends. St. Jude Medical Inc. recently traded at $67.23, a loss of $1.32 over Monday's closing price. The name has a current market capitalization of $19.54 ...
St. Jude Medical, Inc. (NYSE:STJ) President - Americas Joel Becker, Unloaded ... - Feb 4, 2015
In view of the transaction Joel Becker made he is in in the stock market eye today. The President of St. Jude Medical, Inc. (NYSE:STJ) 66.68 -0.12 -0.18% and an insider, unloaded 47,683 shares worth $3,140,511 USD. The average price was $65.9 per share.
St. Jude Medical, Inc. Receives Average Target Price of $72.75 - Stafford Daily
Update: St. Jude Medical, Inc. Insider Trading Disclosure - Bar and Graph Report
Share Price of St. Jude Medical, Inc. Drops by -2.34%
Ashburn Daily - 4 hours ago
St. Jude Medical, Inc. (NYSE:STJ) has dropped 2.34% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 1.23% in the last 4 weeks.
St. Jude Medical Lowered to Underperform at Credit Suisse (STJ)
Dakota Financial News - Feb 24, 2015
St. Jude Medical, Inc. logo Credit Suisse downgraded shares of St. Jude Medical (NYSE:STJ) from an outperform rating to an underperform rating in a report issued on Tuesday, TheFlyOnTheWall.
St. Jude Medical, Inc. to Issue $0.29 Quarterly Dividend (STJ)
The Legacy - Feb 23, 2015
St. Jude Medical logo St. Jude Medical (NYSE:STJ) declared a quarterly dividend on Friday, February 20th, Analyst Ratings News reports.
St. Jude Medical Announces Increase in Quarterly Dividend - Business Wire (press release)
Morningstar Gives "AA-" Credit Rating to St. Jude Medical (STJ)
Dakota Financial News - Feb 26, 2015
St. Jude Medical (NYSE:STJ) has been given an “AA-” credit rating by analysts at Morningstar. The firm's “AA-” rating indicates that the company is a very-low default risk. They also gave their stock a three star rating. A number of other firms have ...
Analyst Rating Update on St. Jude Medical, Inc. - Ashburn Daily
Credit Suisse Lowers St. Jude Medical to Underperform (STJ) - Intercooler